Establishing Cooperation Between Ascentia Sp. z o.o. and the National Library of Chemical Compounds (NLCC)
We are pleased to announce that on 12 October, the National Library of Chemical Compounds (NLCC) entered into a Compound Donation Agreement with Ascentia Sp. z o.o., represented by President of the Management Board Jacek Olczak and Member of the Management Board Marzena Mazur.
Ascentia focuses on the discovery and development of small-molecule compounds and provides research and development services across various stages of the drug discovery process, from molecular target validation to synthetic route optimization of the final clinical candidate compound. Its services are intended for the biotechnology and pharmaceutical sectors, as well as the academic community. Ascentia places strong emphasis on collaboration with research institutions, viewing it as an important element in developing competencies and continuously improving its solutions.
The signing of the Compound Donation Agreement creates new opportunities for the company. Compounds that would otherwise remain unused after the completion of a project can now undergo further evaluation, enabling the identification of additional biological properties. This approach makes it possible to expand knowledge about deposited compounds without incurring additional costs, while simultaneously increasing their research value. The results of the studies may reveal new areas of application and contribute to the identification of compounds with therapeutic potential that could serve as starting points for the development of future medicines.
For the Library, the agreement enriches its collection with compounds exhibiting high drug-likeness, potentially providing valuable starting points for drug discovery programs aimed at identifying molecules that interact with specific molecular targets.
The National Library of Chemical Compounds (NLCC) remains open to collaboration not only with the academic community but also with biotechnology and pharmaceutical companies and research institutes. We invite organizations interested in depositing chemical compounds, conducting bioprofiling studies, and making compounds available for screening campaigns to contact the NLCC. Together, we can enhance the research potential of chemical libraries and contribute to new scientific discoveries and their practical applications.

From the left: Zbigniew Leśnikowski – head of the Medicinal Chemistry Laboratory of IMB PAS and NLCC POL-OPENSCREEN, Jacek Olczak – Founder & CEO at Ascentia Sp. z o.o., Agnieszka Olejniczak – head of the IMB PAS Screening Laboratory,